Current NMR Strategies for Biomarker Discovery - Proteomic and Metabolomic Approaches to Biomarker Discovery

Biology Reference

In-Depth Information

tissues using rotor-synchronized adiabatic pulses.

Magn Reson Med 2005;

143. Schroeder MA, Atherton HJ, Heather LC, et al.

Determining the in vivo regulation of cardiac pyruvate

dehydrogenase based on label

:41 e 8.

129. Kupce E, Keifer PA, Delepierre M. Adiabatic TOCSY

MAS in liquids. J Magn Reson 2001;

flux from hyper-

polarised [1- 13 C]pyruvate. NMR Biomed 2011;

:115 e 20.

130. Andronesi OC, Mintzopoulos D, Struppe J, et al. Solid-

state NMR adiabatic TOBSY sequences provide

enhanced sensitivity for multidimensional high-

resolution magic-angle-spinning

148

980 e 7.

144. Mayer D, Yen Y-F, Josan S, et al. Application of hyper-

polarized 1- 13 C lactate for the in vivo investigation of

cardiac metabolism. NMR Biomed 2012;

1 H MR spectros-

:1119 e 24.

145. Bohndiek SE, Kettunen MI, Hu DE, et al. Hyper-

polarized 1- 13 C-ascorbic and dehydroascorbic acid:

vitamin C as a probe for imaging redox status. JAm

Chem Soc 2011;

:251 e 8.

131. Taylor JL, Wu CL, Cory D, et al. High-resolution

magic angle spinning proton NMR analysis of human

prostate tissue with slow spinning rates. Magn Reson

Med 2003;

copy. J Magn Reson 2008;

193

:11795 e 801.

146. Clatworthy MR, Kettunen MI, Hu DE, et al.

Magnetic resonance imaging with hyperpolarized

1,4- 13 C 2 fumarate allows detection of early renal

acute tubular necrosis. Proc Natl Acad Sci U S A 2012;

109

133

:627 e 32.

132. Wind RA, Hu JZ. In vivo and ex vivo high-resolution

1 H NMR in biological systems using low-speed

magic angle spinning. Prog Nucl Mag Res Sp 2006;

207 e 59.

133. Kauppinen RA, Peet AC. Using magnetic resonance

imaging and spectroscopy in cancer diagnostics and

monitoring preclinical and clinical approaches. Cancer

Biol Ther 2011;

:13374 e 9.

147. Krummenacker JG, Denysenkov VP, Terekhov M,

et al. DNP in MRI: an in-bore approach at 1.5 T.

J Magn Reson 2012;

:94 e 9.

148. Mishkovsky M, Frydman L. Progress in hyper-

polarized ultrafast 2D NMR spectroscopy. Chem Phys

Chem 2008;

215

:665 e 79.

134. Pinker K, Stadlbauer A, Bogner W, et al. Molecular

imaging of cancer: MR spectroscopy and beyond. Eur

J Radiol 2012;

:2340 e 8.

149. Bao Q, Feng J, Chen F, et al. A new automatic baseline

correction method based on iterative method. J Magn

Reson 2012;

:566 e 77.

135. Gillies RJ, Morse DL. In vivo magnetic resonance

spectroscopy in cancer. Annual review of biomedical

engineering. Palo Alto. Annual Reviews; 2005:287 e 326.

136. Glunde K, Bhujwalla ZM. Metabolic tumor imaging

using magnetic resonance spectroscopy. Semin Oncol

2011;

:35 e 43.

150. De Sanctis S, Malloni WM, Kremer W, et al. Singular

spectrum analysis for an automated solvent artifact

removal and baseline correction of 1D NMR spectra.

J Magn Reson 2011;

218

:26 e 41.

137. Mandal PK. In vivo proton magnetic resonance spec-

troscopic signal processing for the absolute quantita-

tion of brain metabolites. Eur

:177 e 83.

151. Xi YX, Rocke DM. Baseline correction for NMR spec-

troscopic metabolomics data analysis. BMC Bio-

informatics 2008;

210

J Radiol 2012;

:324.

152. Skoch A, Jiru F, Bunke J. Spectroscopic imaging: basic

principles. Eur J Radiol 2008;

E653 e E64.

138. Andronesi OC, Ramadan S, Mountford CE, et al.

Low-power adiabatic sequences for localized two-

dimensional chemical shift correlated MR spectros-

copy. Magn Reson Med 2010;

:230 e 9.

153. Giskeødegård GF, Bloemberg TG, Postma G, et al.

Alignment of high resolution magic angle spinning

magnetic resonance spectra using warping methods.

Anal Chim Acta 2010;

:1542 e 56.

139. Andronesi OC, Kim GS, Gerstner E, et al. Detection

of 2-hydroxyglutarate in IDH-mutated glioma

patients by in vivo spectral-editing and 2D correla-

tion magnetic resonance spectroscopy. Sci Transl

Med 2012;

:1 e 11.

154. Savorani F, Tomasi G, Engelsen SB. icoshift: a versatile

tool for the rapid alignment of 1D NMR spectra.

J Magn Reson 2010;

683

202

:190 e 202.

:116. ra4.

140. Yan H, Parsons DW, Jin GL, McLendon R,

Rasheed BA, Yuan WS, et al. IDH1 and IDH2 Muta-

tions in Gliomas. N Engl J Med 2009;

155. Staab JM, O

Connell TM, Gomez SM. Enhancing

metabolomic data analysis with Progressive Con-

sensus Alignment of NMR Spectra (PCANS). BMC

Bioinformatics; 2010:11.

156. Robinette SL, Ajredini R, Rasheed H, et al. Hierar-

chical alignment and full resolution pattern recogni-

tion of 2D NMR spectra: application to nematode

chemical ecology. Anal Chem 2011;

:765 e 73.

141. Parsons DW, Jones S, Zhang XS, et al. An integrated

genomic analysis of human glioblastoma multiforme.

Science 2008;

360

:1807 e 12.

142. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al.

Increase in signal-to-noise ratio of

321

:1649 e 57.

157. Zheng M, Lu P, Liu YZ, et al. 2D NMR metabonomic

analysis: a novel method for automated peak align-

ment. Bioinformatics 2007;

10,000 times in

liquid-state NMR. Proc Natl Acad Sci U S A 2003;

100

10158 e 63.

:2926 e 33.

Proteomic and Metabolomic Approaches to Biomarker Discovery

Search WWH ::

Custom Search

Home